Biomerica Statistics
Total Valuation
Biomerica has a market cap or net worth of $10.34 million. The enterprise value is $8.65 million.
Important Dates
The next estimated earnings date is Friday, April 11, 2025, after market close.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomerica has 18.34 million shares outstanding. The number of shares has increased by 6.07% in one year.
| Current Share Class | 18.34M |
| Shares Outstanding | 18.34M |
| Shares Change (YoY) | +6.07% |
| Shares Change (QoQ) | +1.78% |
| Owned by Insiders (%) | 6.62% |
| Owned by Institutions (%) | 9.63% |
| Float | 17.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.72 |
| Forward PS | n/a |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.17 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -77.33% and return on invested capital (ROIC) is -45.85%.
| Return on Equity (ROE) | -77.33% |
| Return on Assets (ROA) | -38.54% |
| Return on Invested Capital (ROIC) | -45.85% |
| Return on Capital Employed (ROCE) | -109.13% |
| Revenue Per Employee | $87,156 |
| Profits Per Employee | -$87,578 |
| Employee Count | 64 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.75 |
Taxes
In the past 12 months, Biomerica has paid $11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.62% in the last 52 weeks. The beta is -1.17, so Biomerica's price volatility has been lower than the market average.
| Beta (5Y) | -1.17 |
| 52-Week Price Change | -33.62% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 39.70 |
| Average Volume (20 Days) | 183,029 |
Short Selling Information
The latest short interest is 49,683, so 0.27% of the outstanding shares have been sold short.
| Short Interest | 49,683 |
| Short Previous Month | 143,940 |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.29% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, Biomerica had revenue of $5.58 million and -$5.61 million in losses. Loss per share was -$0.33.
| Revenue | 5.58M |
| Gross Profit | 595,000 |
| Operating Income | -5.89M |
| Pretax Income | -6.30M |
| Net Income | -5.61M |
| EBITDA | -5.81M |
| EBIT | -5.89M |
| Loss Per Share | -$0.33 |
Full Income StatementBalance Sheet
The company has $2.37 million in cash and $626,000 in debt, giving a net cash position of $1.75 million or $0.10 per share.
| Cash & Cash Equivalents | 2.37M |
| Total Debt | 626,000 |
| Net Cash | 1.75M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 5.11M |
| Book Value Per Share | 0.28 |
| Working Capital | 4.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.98 million and capital expenditures -$24,000, giving a free cash flow of -$5.00 million.
| Operating Cash Flow | -4.98M |
| Capital Expenditures | -24,000 |
| Free Cash Flow | -5.00M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
Gross margin is 10.67%, with operating and profit margins of -105.61% and -100.48%.
| Gross Margin | 10.67% |
| Operating Margin | -105.61% |
| Pretax Margin | -100.29% |
| Profit Margin | -100.48% |
| EBITDA Margin | -104.09% |
| EBIT Margin | -105.61% |
| FCF Margin | n/a |